Diverse perspectives on science and medicine
One of the most interesting aspects of a newly published study of bevacizumab (Avastin) for older patients with advanced non-small cell lung cancer (NSCLC) is the abstract’s conclusion: “Adding bevacizumab to carboplatin and paclitaxel chemotherapy
You’ve probably already seen the headlines noting the disappointing outcomes of two phase III studies of bevacizumab (brand name Avastin, made by Genentech) for ovarian cancer. I’ve been trying to familiarize myself with the data
Yesterday, the Oncologic Drugs Advisory Committee issued its recommendation to the FDA on the use of Avastin for the treatment of breast cancer: no. Based on clinical trial results, ODAC members voted unanimously that the